CDC42P2

Across TCGA pan-cancer cohorts, CDC42P2 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CDC42P2 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher CDC42P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CDC42P2 expression acts as an unfavorable survival marker, although some lineages such as SKCM and UCS show a favorable association.

STAD, SKCM, and LGG are the cancer types where CDC42P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Quartile	II,III,IV	0.366	0.717	.001	50	view →
SKCM	OS	Median	All	0.960	0.808	<.001	48	view →
LGG	DFS	Tertile	All	0.275	0.453	<.001	43	view →
MESO	OS	Tertile	III,IV	0.221	0.657	.002	36	view →
CHOL	OS	Tertile	II,III,IV	0.019	0.675	<.001	36	view →
LIHC	OS	Tertile	III,IV	0.297	0.655	<.001	36	view →
UVM	DFS	Tertile	All	0.313	0.616	.012	32	view →
READ	OS	Quartile	IV	0.516	0.942	.005	30	view →
BRCA	OS	Tertile	All	0.505	0.601	.010	22	view →
DLBC	DFS	Tertile	III,IV	0.070	0.855	.008	18	view →
UCEC	DFS	Tertile	IV	0.394	0.754	.045	18	view →
ACC	OS	Tertile	II,III,IV	0.156	0.682	.023	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

CDC42P2–STAD (OS)

Open the STAD breakdown →